Categories
Research Insights
NIH: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
This program funds RDCRCs, which are intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research.
Amount: $7,550,000
Due Date: 07/12/2024 (LOI); 08/13/2024 (Full Proposal)